(Q47893462)

6 February 2018

title

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. (English)

1 reference

6 February 2018

0 references

0 references

Usui M

1

1 reference

6 February 2018

Matsuoka H

2

1 reference

6 February 2018

Miyazaki H

3

1 reference

6 February 2018

Ueda S

4

1 reference

6 February 2018

Okuda S

5

1 reference

6 February 2018

Imaizumi T

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 February 2018

published in

Life Sciences

1 reference

6 February 2018

volume

62

1 reference

6 February 2018

issue

26

1 reference

6 February 2018

page(s)

2425-2430

1 reference

6 February 2018

The L-arginine-nitric oxide pathway

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Increased nitric oxide production in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Expression of inducible nitric oxide synthase in failing and non-failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Expression of inducible nitric oxide synthase in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Role of nitric oxide in the regulation of myocardial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Congestive cardiac failure: central role of the arterial blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Metabolism and excretion of nitric oxide in humans. An experimental and clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Nitric oxide production and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900225-2

10.1016/S0024-3205(98)00225-2

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9651109

1 reference

6 February 2018